A decision is expected in the fourth quarter of 2025.

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Lastly, if you’re on or about to get on one of the new weight loss drugs, walk the walk and be patient. It took you quite a ...

Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...

Novo Nordisk remains an industry leader, and currently offers both a 2.7% dividend yield and compelling value that can work ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

Enhanced weight loss effects of NT-0796 and semaglutide in combination ...

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...